Metabolite-specific echo-planar imaging of hyperpolarized [1-- 13 C]pyruvate at 4.7 T by Blazey, Tyler et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2021 
Metabolite-specific echo-planar imaging of hyperpolarized [1-- 13 
C]pyruvate at 4.7 T 
Tyler Blazey 
Galen D. Reed 
Joel R. Garbow 
Cornelius von Morze 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Article
Metabolite-Specific Echo-Planar Imaging of Hyperpolarized
[1-13C]Pyruvate at 4.7 T
Tyler Blazey 1 , Galen D Reed 2 , Joel R Garbow 1 and Cornelius von Morze 1,*


Citation: Blazey, T.; Reed, G.D.;
Garbow, J.R.; von Morze, C.
Metabolite-Specific Echo-Planar
Imaging of Hyperpolarized
[1-13C]Pyruvate at 4.7 T. Tomography
2021, 7, 466–476. https://doi.org/
10.3390/tomography7030040
Academic Editor: Zhaofei (Jeff) Liu
Received: 10 May 2021
Accepted: 6 September 2021
Published: 15 September 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Mallinckrodt Institute of Radiology, Washington University, St. Louis, MO 63110, USA;
blazey@wustl.edu (T.B.); garbow@wustl.edu (J.R.G.)
2 GE Healthcare, Dallas, TX 75390, USA; galen.reed@ge.com
* Correspondence: cornelius@wustl.edu
Abstract: Although hyperpolarization (HP) greatly increases the sensitivity of 13C MR, the usefulness
of HP in vivo is limited by the short lifetime of HP agents. To address this limitation, we developed
an echo-planar (EPI) sequence with spectral-spatial radiofrequency (SSRF) pulses for fast and efficient
metabolite-specific imaging of HP [1-13C]pyruvate and [1-13C]lactate at 4.7 T. The spatial and spectral
selectivity of each SSRF pulse was verified using simulations and phantom testing. EPI and CSI
imaging of the rat abdomen were compared in the same rat after injecting HP [1-13C]pyruvate. A
procedure was also developed to automatically set the SSRF excitation pulse frequencies based on
real-time scanner feedback. The most significant results of this study are the demonstration that a
greater spatial and temporal resolution is attainable by metabolite-specific EPI as compared with
CSI, and the enhanced lifetime of the HP signal in EPI, which is attributable to the independent flip
angle control between metabolites. Real-time center frequency adjustment was also highly effective
for minimizing off-resonance effects. To the best of our knowledge, this is the first demonstration of
metabolite-specific HP 13C EPI at 4.7 T. In conclusion, metabolite-specific EPI using SSRF pulses is an
effective way to image HP [1-13C]pyruvate and [1-13C]lactate at 4.7 T.
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1. Introduction
Carbon-13 magnetic resonance spectroscopy (13C MRS) can provide noninvasive
access to specific elements of intermediary metabolism in vivo. However, applicability
for medical imaging has been hampered by the low in vivo concentration and intrinsic
sensitivity of 13C. Hyperpolarization can overcome these limitations by amplifying the po-
larization of 13C by up to five orders or magnitude, through the process of dynamic nuclear
polarization (DNP) [1], or by other methods such as parahydrogen-induced polarization
(PHIP) [2]. Hyperpolarization vastly increases the signal-to-noise ratio (SNR) of 13C MRS,
making it possible to capture dynamic metabolic images in vivo [3].
The main limitation of hyperpolarized (HP) 13C MRS is the short lifetime of HP
magnetization. Polarization is subject to rapid and irreversible spin–lattice (T1) relaxation,
and therefore the most useful HP agents have long T1 relaxation times. To date, the
most widely investigated HP agent is [1-13C]pyruvate [4], which has a T1 of about 65 s
in aqueous solution at 4.7 T. As it can be used to monitor the conversion of pyruvate to
lactate, [1-13C]pyruvate has primarily been used in the context of cancer imaging, as many
tumors exhibit excessive aerobic glycolysis [5].
The short lifetime of hyperpolarized species demands rapid, efficient MR pulse se-
quences. In addition to T1 relaxation, polarization is also consumed by T2 relaxation
following each RF excitation pulse. It is therefore advantageous to develop pulse sequences
that conserve as much polarization as possible while still providing a sufficient SNR. Initial
HP 13C metabolic imaging studies used chemical shift imaging (CSI) [3,6], which requires
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a separate RF excitation for each k-space location. This is less than ideal for HP imaging,
since it requires many excitations. The slow CSI acquisition is also highly susceptible to
motion-induced blurring as well as k-space filtering effects resulting from relaxation.
Accelerated pulse sequences that have been used successfully for HP metabolic
imaging include echo-planar spectroscopic imaging (EPSI) [7,8] and echo-planar imaging
(EPI) [9–11]. As with CSI, EPSI also acquires a 13C spectrum at each voxel but encodes
an entire line of spatial k-space data per excitation, providing significant acceleration [12].
Alternatively, the EPI approach eschews the acquisition of localized spectra in favor of
metabolite-specific imaging, with single-shot EPI acquiring the entire k-space trajectory
with a single excitation [13]. This not only preserves polarization by reducing the number
of RF pulses but can also greatly improve the temporal resolution.
Since spectral components are not easily resolved in EPI, it is advantageous to design
RF excitations with both spatial and spectral selectivity [14]. Such excitation pulses are
typically referred to as spectral-spatial RF (SSRF) pulses [15–17]. With a metabolite-specific
SSRF pulse, each EPI acquisition provides an image of a single metabolite at a single
point in time. Given the fast acquisition time of a typical EPI sequence (~100 ms per
slice), images of multiple metabolites can be collected rapidly in succession at each time
point. A significant further advantage of metabolite-specific excitation is that a different
flip angle can be used for each metabolite. Typically, a smaller flip angle is used on the
injected substrate (e.g., [1-13C]pyruvate) to preserve polarization for metabolic conversion
to downstream metabolites [16]. A larger flip angle is then used for the polarized product
(e.g., [1-13C]lactate), as it is present in smaller amounts than the substrate and therefore
benefits from the increased SNR provided by a larger flip angle. Furthermore, the polarized
product consumed by the RF pulse can be regenerated from the substrate metabolically.
The purpose of this study was to develop an EPI sequence for efficiently imaging
HP [1-13C]pyruvate and its metabolic product [1-13C]lactate at 4.7 T. To our knowledge,
this is the first report of HP 13C EPI at 4.7 T based on metabolite-specific SSRF excitation.
To accomplish this, we designed custom SSRF excitation pulses for each metabolite and
integrated them into a robust existing flyback EPI sequence. We also developed a pulse
sequence for measuring SSRF profiles on our scanner platform (Agilent), which we share
online along with the new pulse waveforms. In addition, we developed a fully automated
procedure for determining and applying appropriate center frequency shifts for the 13C
excitation pulses (code also shared), based on real-time scanner feedback to make our
sequence more robust to off-resonance effects.
2. Materials and Methods
2.1. Sequence Development
We developed a pulse sequence for metabolite-specific 2D EPI of HP [1-13C]pyruvate
and its downstream metabolic product [1-13C]lactate at 4.7 T (50.7 MHz). As diagrammed
in Figure 1, pyruvate and lactate images were acquired alternately, with a user-specified
time delay between each rapid set of metabolite images. To accomplish this, we designed
custom SSRF pulses to specifically excite either [1-13C]lactate or [1-13C]pyruvate signals
at a given spatial location while maximally avoiding all other related species, including
each metabolite’s redox partner as well as [1-13C]pyruvate-hydrate and [1-13C]alanine.
For a more robust performance, SSRF excitation was performed using flyback gradient
waveforms. The custom pulse waveforms are shown in Figure 2. SSRF pulse widths
were 6.3 ms for pyruvate-only 20◦ excitation (B1,peak = 0.2 G) and 13.3 ms for lactate-only
90◦ excitation (B1,peak = 0.3 G). Each pulse was designed for uniform excitation over a
±0.5 ppm passband, with a time–bandwidth product of 3.5 and maximum ripple of 1%.
Pulses were designed using the “Spectral-Spatial RF Pulse Design for MRI and MRSI”
MATLAB package (https://github.com/LarsonLab/Spectral-Spatial-RF-Pulse-Design,
accessed on 12 May 2021) [16] and integrated with a previously described EPI pulse
sequence used for HP 13C MRI studies at 14 T [18]. As with the excitation pulses, flyback
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EPI readout waveforms were employed for a robust imaging performance without the
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Figure 1. Pulse sequence diagram for metabolite-specific 2D EPI imaging of [1-13C]pyruvate and [1-13C]lactate at 4.7 T. An
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Figure 2. F pulse avefor s for pyruvate and lactate SSRF pulses (top row). The solid black lines are the pulse magnitude,
while t e dashed blue and red lines ar the real and imagin ry components, re pectively. The gradient waveforms are
shown o the bottom row.
e also eveloped a lse se ence for ickly easuring SS F excitation profiles
(both spectral and spatial) on the Agilent RI platform. This was accomplished by mod-
ifying a vendor-supplied 1 profile i aging seq ence. Since several seq ence changes
ere necessary to move the slice and readout gradients onto the same axis for pulse
profile measurement, and no existing tools were available, we opted to share the source
code for the modified SSRF profile sequence online (https://github.com/cvonmorze/
SSRFprofileAgilent, accessed 15 May 2021). To maximize the SNR, all profile measure-
ments were performed in 1H mode using a long cylindrical water phantom. For profile
testing, the pulse center frequency was swept over a range of ±600 Hz, slightly exceeding
the spectral bandwidth of both custom pulses. Resulting experimental profiles were com-
pared to magnetization profiles computed in simulation. For comparison, the experimental
profiles were interpolated to match the spatial and spectral range of the simulated profiles.
2.2. In Vivo Testing
For the in vivo testing, 100 mM HP [1-13C]pyruvate was generated in a GE 5T SPINlab
hyperpolarizer and quickly transferred to a 4.7 T MRI scanner (Agilent, Santa Clara, CA,
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USA) equipped with a 72 mm i.d. dual-tuned 13C/1H volume coil (ExtendMR, Milpitas,
CA, USA). The contrast materials were transferred to the MRI scanner located one floor
below the polarizer through a sample drop chute installed adjacent to the polarizer while
protected magnetically inside a handheld electromagnet carrier with an internal static
field of 50 G [19]. The transfer time was ~30 s. Approximately 20 s after 2.5 mL of HP
pyruvate was injected (~12 s injection) into the tail vein of an anesthetized (isoflurane)
rat, images of pyruvate and lactate were acquired every 3 s for 60 s (20 images for each
metabolite). Images were acquired coronally through the rat body, with a 16 × 16 matrix
(80 × 80 mm2 FOV) for a 5 mm in-plane resolution and 20 mm slice thickness. To preserve
HP magnetization for metabolic conversion over time, a lower flip angle was applied on
the injected [1-13C]pyruvate substrate (20◦) compared with the downstream [1-13C]lactate
product (90◦).
For comparison with a conventional spectroscopic imaging approach, we also per-
formed 2D dynamic chemical shift imaging (CSI) following an identical injection of HP
pyruvate during the same imaging session. Six dynamic CSI images with a tempo-
ral resolution of approximately 6 s were acquired starting 20 s after the start of injec-
tion. Imaging parameters for the CSI sequence were as follows: matrix = 8 × 8, spatial
resolution = 10 × 10 mm2, FOV = 80 × 80 mm2, flip angle = 10◦ (hard pulse), spectral band-
width = 25 kHz, spectral points = 2048, TR = 82 ms. For anatomic reference, a 1H gradient
echo multislice (GEMS) image was also acquired (matrix = 128 × 128, FOV = 80 × 80 mm2).
During imaging, a Gd-doped aqueous [13C]urea vial phantom was placed on the
posterior aspect of the rat’s abdomen. This phantom served two purposes. First, it allowed
us to calibrate the power of the RF pulses. Based on hard pulse calibration, our 72 mm
volume 13C coil provides a maximum B1 of ~2 G when mated with our scanner’s 1 kW
low-band amplifier (Model 3200, American Microwave Technology, Anaheim, CA, USA),
which must be scaled down for the SSRF excitations according to the peak B1 values
quoted above. Second, for our initial experiments, we used the resonance frequency of the
[13C]urea phantom in the CSI experiment as a reference for the frequency offsets used by
the pyruvate-only and lactate-only SSRF excitation pulses. To ensure that the frequency
offsets were accurate, we also used the CSI experiment to measure the in vivo resonance
frequencies of HP pyruvate and lactate. Later, we developed a procedure that automatically
determines and applies the correct frequency offsets in real time at the start of the HP
imaging experiment.
For this automated procedure, following the injection of [1-13C]pyruvate, a single-slice
selective 13C spectrum was acquired from a 4 cm-thick axial slice including the liver and
kidneys but excluding the heart and lungs. A low 5◦ flip angle was used to preserve
magnetization for subsequent EPI scans. Other relevant parameters were as follows:
spectral bandwidth = 10 kHz, spectral points = 2048, TR = 1.2 s, and TE = 0.67 ms. Next,
a custom script based on VNMRJ commands was triggered automatically to move the
scanner center frequency to the pyruvate resonance and set the frequency offsets for both
pulses relative to pyruvate. Finally, the custom script triggered the dynamic EPI acquisition.
Since the SSRF passbands were not centered on the resonances of interest, in-plane
reconstruction shifts were applied to all EPI images to account for frequency offset between
each metabolite and the center frequency of the pulse. These shifts were determined by the
spectral distance between each pulse center frequency and the corresponding metabolite
of interest, separately as a fraction of the imaging bandwidth along the frequency- and
phase-encoding dimensions.
2.3. Imaging Processing
For CSI, an exponential apodization filter of 12 Hz was applied, and metabolite images
were computed by taking the peak height of each resonance of interest. Image processing
was performed using the Nmrglue [20], Numpy [21], Scipy [22], and TensorLy [23] packages
in Python.
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3. Results
To verify that the custom SSRF pulses generate the expected spatial and spectral
excitation profiles, we compared the simulated profiles of the resulting transverse magneti-
zation as a function of space and frequency against experimental profiles measured inside
the scanner. These results were obtained by scanning a long, narrow cylindrical water
phantom using the customized 1D profile sequence in 1H mode. As depicted in Figure 3,
good congruence was observed between the simulated and experimental magnetization
profiles for both the pyruvate-only and lactate-only SSRF excitation pulses. The pyruvate
passband effectively captures the pyruvate resonance (172.0 ppm) while excluding the
resonances for lactate (184.3 ppm), alanine (177.7 ppm), and pyruvate hydrate (180.4 ppm).
The narrower passband of the lactate-only excitation pulse likewise effectively excites
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i ey of a rat follo ing injection of [1-13 ] t . I i t first c l ( ) ere acquired
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Using EPI with metabolite-specific SSRF excitation pulses provided an improved
spatial resolution as compared with CSI (5 mm vs. 10 mm in-plane) and also allowed us to
better characterize the temporal dynamics of the HP magnetization (Figures 5 and 6). The
temporal resolution obtained using EPI was 3 s and could even have been much shorter,
whereas it was 6 s with CSI. Furthermore, despite the additional time points, EPI preserved
the HP magnetization for a significantly longer amount of time. Although the early EPI
frames contain the majority of the signal, we were able to detect both HP pyruvate and
lactate signals 30 s from the start of imaging (Figures 5 and 6). Conversely, with CSI, there
was little to no HP signal remaining 20 s after the start of imaging (Figure 6). In addition,
it is notable that CSI resulted in larger HP signals in the rat chest, most likely cardiac
in origin.
For the i proved EPI acquisition ith fully auto ated center frequency calibration,
an exa ple initial 4 c abdo inal slab spectru is sho n in Figure 7 . Selected i ages
fro t e I series that followed are shown in Figure 7B, showing a comparable SNR
and signal lifetime to the prior EPI data in which CSI was used to confirm the necessary
frequency offsets (Figure 5).







Figure 6. Dynamic metabolite curves  for  [1‐13C]pyruvate  (1st column) and  [1‐13C]lactate  (2nd column), acquired using 
metabolite‐specific EPI (1st row) or CSI (2nd row). Red lines are the hyperpolarized signal from the liver, while blue lines 
are from the kidney. Signals are shown in approximate SNR units. Note that the SNR scale is different for each subplot. 
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The  fact  that  single‐shot EPI acquires an entire  image with a  single RF excitation 
makes it an excellent fit for imaging HP compounds. Most HP agents have T1 constants of 
a minute or less [24], with T1 decreasing as the field strength increases above ~1 tesla [25]. 





















Figure 7. 13C frequency spectrum acquired from 4 cm-thick slab that included the rat liver and kidneys but excluded the
heart and lungs (A). The spectrum was obtained just after the injection of [1-13C]pyruvate using a small flip angle. An
automated script was used to move the sca ner center frequency from the urea resonance (dashed line) to that of pyruvate.
The script then tri gered the start of an EPI acquisition that used SRF frequency offsets computed relative to the pyruvate
resonance (B). Both pyruvate (1st row) and lactate images (2nd row) were of similar quality to prior experiments in which
the frequency offsets were computed using a separate HP injection (Figures 4 and 5).
4. Discussion
We have demonstrated that EPI with SRF pulses is an effective method for imaging
HP compounds at 4.7 . r custo SSRF pulses were shown to sel ctively excite he
r sona ce of interest (pyruvate or lact te) without exciting earby metabolites. Subsequ nt
in vivo imaging showed improved image quality and dynamics with EPI compared with
conve tio al CSI acquisition. Fi ally, to mini ize off-resonance effects, we developed an
automated pre-scan procedure to determine and apply the correct pulse c nter frequ cies
based on real-time [1-13C]pyruvate data.
The fact t at si le-s t EPI acquires an entire image with a single RF excitation makes
it an excellent fit for imaging HP compounds. Most HP agents have T1 constants of a minute
or less [24], with T1 decreasing as the field strength increases above ~1 tesla [25]. Therefore,
a prerequisite for any HP imaging method is the ability to acquire images quickly. It is also
potentially advantageous to use as few RF excitations as possible, as each pulse consumes
the non-renewable polarization. EPI satisfies both of these criteria, greatly enhancing
our ability to measure signal dynamics in vivo. Pyruvate and lactate signals were both
detectable 30 s after the start of imaging with EPI. By contrast, after 30 s, essentially no
signal was detected with CSI (which requires 64 excitations per image, as configured).
Furthermore, our EPI images were acquired with twice the temporal resolution vs. our CSI
acquisition and could, if necessary, be collected much more quickly.
A large fraction of the performance improvement with EPI was probably due to the
ability of our SSRF pulses to independently control the flip angle for individual metabolites.
This allowed us to use a larger flip angle on lactate (increasing the SNR) while, at the same
time, using a smaller flip angle on pyruvate (preserving magnetization for subsequent
excitations). It should be noted, however, that the use of different flip angles between
metabolites, along with uncertainties regarding the polarization level at the time of injection
and rates of depolarization within different local microenvironments, prevented us from
obtaining quantitative estimates of metabolite concentrations.
Although this is the first report using HP 13C EPI with SSRF pulses at 4.7 T, several
investigators have previously used similar techniques at other field strengths. One of
the first reports was by Cunningham et al., who used flyback EPI along with an SSRF
pulse to measure lactate formed after injecting [1-13C]pyruvate at 3 T [15]. A subsequent
study by Miller et al. developed SSRF pulses for lactate, pyruvate, and bicarbonate for use
with flyback EPI at 7.0 T [9]. Other investigators have designed SSRF pulses for use with
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symmetric EPI or spiral readout trajectories [17,26]. Of particular interest is the symmetric
EPI method used by Gordon et al. [26]. Whereas the flyback EPI proposed here only
acquires data during the negative lobes of the readout gradient, symmetric EPI uses both
the positive and negatives lobes during readout. This can result in an increase in efficiency,
and thus in the SNR. Using a 13C phantom, Gordon et al. reported up to a 2× increase
in the SNR with symmetric EPI over flyback EPI [26]. However, in the symmetric EPI
approach, differences in odd/even k-space lines can introduce Nyquist ghosting artifacts.
The primary limitation of SSRF excitation for HP 13C MRI is that the resonance
frequency for each metabolite must be known with high precision prior to acquiring
data. If an incorrect frequency offset is used, the desired flip angle may not be achieved,
and the pulse may excite other parts of the spectrum instead of the intended resonance.
Furthermore, the resulting signal may be shifted in space as the spectral location of each
metabolite must be known to correctly reconstruct the data.
One simple method for properly setting the frequency offsets is to express them
relative to a known reference. For example, Cunningham et al. and Lau et al. used external
lactate [15] and urea [17] phantoms, respectively. In this case, if the reference is not the
same chemical species as the metabolite of interest, the frequency difference between the
two resonances must be assumed. This is only a very minor weakness, however, as the
chemical shift between individual metabolites at the same spatial location is generally
highly consistent. However, it is not guaranteed that the resonance frequency of the
reference is the same in the tissue of interest as it is in the phantom due to variations in the
B0 field. B0 variations can be accounted for, however, through the use of a B0 field map [9].
We chose an alternative approach in which a single 13C spectrum is acquired over
the region of interest after injection of [1-13C]pyruvate, but prior to EPI acquisition. This
real-time scan feedback was used to adjust the pulse center frequencies automatically,
thereby mitigating the effects of frequency shifts caused by B0 variations and eliminating
the need to know the exact resonance frequency of [1-13C]pyruvate a priori. We found
that this approach compares favorably with using a separate CSI acquisition to measure
the in vivo frequencies for each metabolite, which is far more cumbersome. Despite these
advantages, relatively few investigators have previously utilized such an approach [27–29].
This is probably mainly because most scanner environments cannot easily be programmed
to adapt to real-time imaging feedback. The VNMRJ scanner environment is particularly
amenable to such customization, facilitating our approach. However, a limitation of
our strategy is it only measures the appropriate frequency offset for [1-13C]pyruvate,
again applying prior knowledge of the spectral separation between pyruvate and lactate.
However, as noted above, this is only a minor weakness as these spacings are generally
consistent over a small spatial region. While, in principle, it is possible to also use the
pre-scan spectrum to identify the location of the lactate resonance, we chose not to attempt
this as the lactate peak is much harder to identify at this early time point due to its low
concentration, particularly with the small flip angle necessary to preserve polarization for
the subsequent EPI scan.
5. Conclusions
We have demonstrated that SSRF pulses can be used along with flyback EPI to quickly
and efficiently image HP [1-13C]pyruvate and [1-13C]lactate at 4.7 T. Using EPI resulted
in improvements in the signal lifetime and temporal resolution over a conventional CSI
approach, without sacrificing the spatial resolution or image quality. We also developed
an automated pre-scan procedure to make our sequence more robust to off-resonance
effects. Taken together, these tools substantially improved the quality of HP imaging in our
laboratory. We have made our custom SSRF pulses and source code (SSRF profile sequence
and automated pre-scan procedure) available online so that other investigators can use
these methods as well.
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